Advanced search
Publication Cover
Pediatric Hematology and Oncology Volume 27, 2010 - Issue 1
Submit an article Journal homepage
52
Views
4
CrossRef citations to date
0
Altmetric
Case Reports

A 9-MONTH-OLD INFANT WITH ACQUIRED IDIOPATHIC THROMBOTIC THROMBOCYTOPENIC PURPURA CAUSED BY INHIBITORY IgG-AUTOANTIBODY TO ADAMTS13

Atsushi SatoDepartment of Hematology and Oncology, Miyagi Children's Hospital, Sendai, JapanCorrespondence[email protected]
, MD, PhD,
Yoshiyuki HoshiDepartment of Hematology and Oncology, Miyagi Children's Hospital, Sendai, Japan
, MD, PhD,
Masaei OnumaDepartment of Hematology and Oncology, Miyagi Children's Hospital, Sendai, Japan
, MD,
Ryusuke SatoDepartment of Pediatrics, Tokyo Medical and Dental University, Tokyo, Japan
, MD, PhD,
Yukiko TsunematsuDepartment of Strategic Medicine, Division of Pediatric Oncology, National Center for Child Health and Development, Tokyo, Japan
, MD, PhD,
Ayami IsonishiDepartment of Blood Transfusion Medicine, Nara Medical University, Nara, Japan
, BS,
Masanori MatsumotoDepartment of Blood Transfusion Medicine, Nara Medical University, Nara, Japan
, MD, PhD,
Yoshihiro FujimuraDepartment of Blood Transfusion Medicine, Nara Medical University, Nara, Japan
, MD, PhD &
Masue ImaizumiDepartment of Hematology and Oncology, Miyagi Children's Hospital, Sendai, Japan
, MD, PhD show all
Pages 53-58 | Accepted 09 Oct 2009, Published online: 02 Feb 2010

REFERENCES

  • Fujimura Y, Matsumoto M, Yagi H, . Von Willebrand factor-cleaving protease and Upshaw-Schulman syndrome. Int J Hematol. 2002;75:25–34.
  • Loirat C, Girma JP, Desconclois C, . Thrombotic thrombocytopenic purpura related to severe ADAMTS13 deficiency in children. Pediatr Nephrol. 2008;24: Epub.
  • Mannucci PM, Peyvandi F. TTP and ADAMTS13: When is testing appropriate? Hematol Am Soc Hematol Educ Program. 2007;121–126.
  • Levy GG, Nichols WC, Lian EC, . Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature. 2001;413:488–494.
  • Shibagaki Y, Matsumoto M, Kokame K, . Novel compound heterozygote mutations (H234Q/R1206X) of the ADAMTS13 gene in an adult patient with Upshaw–Schulman syndrome showing predominant episodes of repeated acute renal failure. Nephrol Dial Transplant. 2006;21:1289–1292.
  • Furlan M, Robles R, Galbusera M, . von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic–uremic syndrome. N Engl J Med. 1998;339:1578–1584.
  • Sadler JE, Moake JL, Miyata T, . Recent advances in thrombotic thrombocytopenic purpura. Hematol Am Soc Hematol Educ Program. 2004;407–423.
  • Loirat C, Veyradier A, Girma JP, . Thrombotic thrombocytopenic purpura associated with von Willebrand factor-cleaving protease (ADAMTS13) deficiency in children. Semin Thromb Hemost. 2006;32:90–97.
  • Ashida A, Nakamura H, Yoden A, . Successful treatment of a young infant who developed high-titer inhibitors against VWF-cleaving protease (ADAMTS-13): important discrimination from Upshaw–Schulman syndrome. Am J Hematol. 2002;71:318–322.
  • Schneppenheim R, Budde U, Hassenpflug W, . Severe ADAMTS-13 deficiency in childhood. Semin Hematol. 2004;41:83–89.
  • Fontana S, Kremer Hovinga JA, Lammle B, . Treatment of thrombotic thrombocytopenic purpura. Vox Sang. 2006;90:245–254.
  • Tsai HM, Li A, Rock G. Inhibitors of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura. Clin Lab. 2001;47:387–392.
  • Tsai H-M. Thrombotic thrombocytopenic purpura: a thrombotic disorder caused by ADAMTS13 deficiency. Hematol Oncol Clin North Am. 2007;21:609–632.
  • Horton TM, Stone JD, Yee D, . Case series of thrombotic thrombocytopenic purpura in children and adolescents. J Pediatr Hematol Oncol. 2003;25:336–339.
  • Kokame K, Kokubo Y, Okayama A, . FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay. Br J Haematol. 2005;129:93–100.
  • Kato S, Matsumoto M, Matsuyama T, . Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS13 activity. Transfusion. 2006;46:1444–1452.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.